Latest news
Cullinan Therapeutics (NASDAQ:CGEM) Issues Quarterly Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:25:30 GMTThe Bull Case For Cullinan Therapeutics (CGEM) Could Change Following FDA-Backed Phase 2 CLN-049 Trial - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:16:05 GMTRenaissance Technologies LLC Sells 307,595 Shares of Cullinan Therapeutics, Inc. $CGEM - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:44:45 GMTCullinan Therapeutics (NASDAQ:CGEM) Shares Jump on Inline Q2 Earnings and Pipeline Milestones - ChartMillChartMill · Fri, 07 Aug 2026 05:28:53 GMTCullinan Q2 2026 earnings: Lower expenses narrow the net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 11:56:57 GMTCullinan to begin potentially registrational acute myeloid leukemia study in Q3 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT2026 Rolls-Royce Cullinan vs 2026 Bentley Bentayga - driving.cadriving.ca · Tue, 04 Aug 2026 22:25:20 GMTCricket is fooling itself if it thinks most players can play all formats successfully - CricinfoCricinfo · Mon, 03 Aug 2026 09:21:27 GMT